787640-35-1

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-
• CAS NO: 787640-35-1
• Molecular Weight: 365.545
• Mol File: 787640-35-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-(787640-35-1)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-(787640-35-1)

Safety Data

• Hazardous Substances Data: 787640-35-1(Hazardous Substances Data)

Usage

General Description

The chemical "1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-" is a phenylmethyl ester derived from 1-pyrrolidinecarboxylic acid and 2-hydroxymethyl-4-[(1,1-dimethylethyl)dimethylsilyl]oxy. It has a molecular formula of C21H35NO5Si and a molecular weight of 413.600 g/mol. This chemical belongs to the class of organic compounds known as esters, which are formed by the bonding of a carbonyl group to two alkyl or aryl groups. "1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-" is a chiral compound with 2 stereocenters and an (R,R) configuration, and its precise uses and applications in various fields are yet to be fully explored.

Upstream product

• 36901-86-7 cis-hydroxy-D-proline 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 501-53-1 benzyl chloroformate 
• 2584-71-6 cis-hydroxy-D-proline 
• 130930-25-5 (R,R)-4-hydroxy-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid 
• 51-35-4 4R-4-hydroxyproline 
• 155075-23-3 (2R,4R)-1-benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 
• 114676-59-4 (2R,4R)-4-hydroxy-2-methoxycarbonylpyrrolidine hydrochloride 
• 77449-94-6 (2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid hydrochloride 
• 444313-67-1 (1R,4R)-5-acetyl-2-oxa-5-azabicyclo[2.2.1]heptan-3-one 
• 1004529-93-4 (2R,4R)-2-ethoxycarbonyl-4-[(tert-butyl)dimethylsilyloxy]-N-(benzyloxycarbonyl)pyrrolidine 
• 787640-34-0 (2R,4R)-1-benzyl 2-methyl 4-((tert-butyldimethylsilyl)oxy)pyrrolidine-1,2-dicarboxylate 

Downstream Products

• 787640-37-3 (1R,4R)-benzyl 2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate 
• 661470-56-0 (1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptane 
• 1269622-76-5 (2R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-2-(4-pyridin-3-yl-[1,2,3]triazol-1-ylmethyl)-pyrrolidine-1-carboxylic acid benzyl ester 
• 1269622-75-4 (2R,4R)-2-azidomethyl-4-(tert-butyl-dimethyl-silanyloxy)-pyrrolidine-1-carboxylic acid benzyl ester 
• 1194056-54-6 (2R,4R)-benzyl-4-(tert-butyldimethylsilyloxy)-2-formylpyrrolidine-1-carboxylate 

Relevant articles and documents

COMPOUNDS

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.

ANTIBACTERIAL FLUOROQUINOLONE ANALOGS

Compounds having antibacterial activity are disclosed. The compunds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, D, E, G, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

The present invention is directed to compounds of the formula I: Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.